TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.39 CNY | +4.20% |
|
+2.76% | -.--% |
| Sales 2024 * | 2.76B 381M 30.58B | Sales 2025 * | 3.26B 450M 36.06B | Capitalization | 7.58B 1.05B 83.99B |
|---|---|---|---|---|---|
| Net income 2024 * | 530M 73.21M 5.87B | Net income 2025 * | 620M 85.64M 6.87B | EV / Sales 2024 * | 3.04 x |
| Net Debt 2024 * | 820M 113M 9.09B | Net Debt 2025 * | 874M 121M 9.68B | EV / Sales 2025 * | 2.6 x |
| P/E ratio 2024 * |
14.4
x | P/E ratio 2025 * |
12.3
x | Employees | 2,496 |
| Yield 2024 * |
2.55% | Yield 2025 * |
3.1% | Free-Float | 27.34% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.20% | ||
| 1 week | +2.76% | ||
| Current month | +13.58% | ||
| 1 month | +13.58% | ||
| 3 months | +14.46% | ||
| 6 months | -2.50% |
1 week
15.26
16.70
1 month
15.1616.70
Current year
11.5516.70
1 year
11.5522.23
3 years
11.5544.41
5 years
10.7144.41
10 years
6.3044.41
| Managers | Title | Age | Since |
|---|---|---|---|
Shou Jun Li
CEO | Chief Executive Officer | 61 | 02/08/98 |
Chang Chang Li
DFI | Director of Finance/CFO | 49 | 27/04/22 |
Xiu Tong Zhu
BRD | Director/Board Member | 43 | 26/10/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shou Jun Li
CEO | Chief Executive Officer | 61 | 02/08/98 |
Zhong Hua Zhou
CHM | Chairman | 61 | 23/12/18 |
Lei Xu
BRD | Director/Board Member | 51 | 24/12/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 16.39 | +4.20% | 11,456,700 |
| 29/04/24 | 15.73 | +1.42% | 5,685,720 |
| 26/04/24 | 15.51 | -2.45% | 7,832,924 |
| 25/04/24 | 15.9 | -.--% | 3,452,775 |
| 24/04/24 | 15.9 | -1.06% | 5,127,475 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.
Sector
Pharmaceuticals
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
16.39
CNY
Average target price
21.14
CNY
Spread / Average Target
+28.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 1.05B | |
| -12.05% | 6.49B | |
| +24.75% | 3.7B | |
| -3.48% | 3.11B | |
| +2.36% | 1.44B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -7.91% | 1.19B | |
| -10.84% | 1.17B | |
| -7.15% | 818M |
- Stock Market
- Equities
- 300119 Stock
